Business
Announcement on Subsidiary's Acquisition of U.S. FDA Approval for Additional Production Site of Vecuronium Bromide for Injection
Announcement on Subsidiary's Acquisition of U.S. FDA Approval for Additional Production Site of Vecuronium Bromide for Injection
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Subsidiary's Acquisition of U.S. FDA Approval for Additional Production Site of Vecuronium Bromide for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment